Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 117 results found. Search for [ Indian generic drug manufacturers ]

Results 1 to 21 of 117
PTI
June 1, 2021
Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India


BusinessToday.In
May 11, 2021
The three Indian drugmakers - Cipla Ltd, Lupin Ltd, and Sun Pharma will collaborate with Lilly to manufacture and distribute Baricitinib in India. The drug is approved by the Central Drugs Standard Control Organization (CDSCO) for restricted emergency use in India


Joe C Mathew
May 10, 2021
Lilly said the company is also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses. These voluntary licensing agreements will ensure high quality manufacturing and accessibility of Baricitinib


BusinessToday.In
April 28, 2021
The company, known as Merck in the US and Canada, has inked pacts with Cipla, Dr Reddy's Laboratories, Sun Pharma, Hetero Labs, and Emcure Pharmaceuticals


Joe C Mathew and Nidhi Singal
New Delhi, April 14, 2021
The Production Linked Incentive Scheme aims to build an Indian manufacturing base across 13 key sectors. What works. What doesn't


Vamsi Maddipatla
February 1, 2021
With a cohesive effort from both public and private players, the Indian bio-pharma industry has the potential to unlock tremendous growth over the next few years


BusinessToday.In
December 3, 2020
India Stock Market Highlights Today: Maruti Suzuki, Hindalco, Tata Steel and GAIL India were the top gainers on Nifty rising up to 3.62%. SBI Life Insurance, Infosys, Bharti Airtel and Axis Bank were the top losers falling up to 1.79% on Nifty


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


Joe C Mathew
October 7, 2020
Parallel to the WTO proposal, SJM wants India to initiate measures under Section 66 of the Patents Act for the cancelation of the patent on Remdesivir


PB Jayakumar
September 3, 2020
WHO's recommendation is based on three new studies, plus four other earlier trials, all involving a drug from the family of corticosteroids


PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical


Reuters
June 26, 2020
In April, India also tightened rules for investments from neighbouring countries, including China, to prevent opportunistic takeovers after the pandemic


Reuters
June 23, 2020
Indian drugmakers Hetero Labs and Cipla Ltd on Sunday gained approval to begin selling their generic versions of remdesivir in the country


Joe C Mathew
June 11, 2020
The multistate law suit filed by Maryland Attorney General Brian E. Frosh on June 10 alleges a broad conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States


BusinessToday.In
June 11, 2020
Stock Market LIVE Updates: Companies set to announce their earnings are Shriram City Union Finance, Westlife, JK Agri Genetics, KSB, KNR Constructions, Sundaram Fasteners, Redington, Ind Bank Housing.


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


PB Jayakumar
May 27, 2020
Approval to explore new COVID-19 therapies, licensing and supply deals to manufacture drugs to treat the virus and fast approvals for plants under regulatory scanner have turned the fortunes of most of these companies


PB Jayakumar
New Delhi, May 12, 2020
Pharmaceutical players will set up plants in major markets, go for more automation and focus on digital marketing


Joe C Mathew
New Delhi, April 18, 2020
Coronavirus news: Indian Council of Medical Research (ICMR) had hinted that if the medicine proves effective, and if cost effective versions of the medicine can be made available through Indian generic companies, then it can be considered for treating COVID-19 patients in India


PB Jayakumar
New Delhi, April 15, 2020
How healthcare, FMCG, pharma, petrochemical and IT companies will turn the capabilities acquired during the coronavirus crisis into new businesses in India and abroad


PAGES 1 OF 6  12345